Publications

These guidelines provide new and updated recommendations and good practice statements in the following areas: starting ART, including initiating treatment outside the clinic and support for same-day ART start; frequency of clinical visits and ART refills; measuring adherence; tracing and re-engagement in care for all populations; psychosocial support for adolescents living with HIV; task sharing for diagnostic services; and service integration. This guideline seeks to provide support to Member States, programme managers, health workers and other stakeholders seeking to achieve national and international goals to end the HIV epidemic as a public health threat by 2030.

Persons with disabilities are disproportionately impacted by COVID-19, both directly because of infection, and indirectly because of restrictions to reduce the spread of the virus. Persons with disabilities are a diverse group, and the risks, barriers and impacts faced by them will vary in different contexts according to, among other factors, their age, gender identity, type of disability, ethnicity, sexual orientation, and migration status. This document presents considerations and actions for the following stakeholders to ensure equity in access to vaccination against COVID‑19 for persons with disabilities.

The WHO 2021 guideline promotes the use of optimal antiretroviral treatment (ART) regimens in all populations. Though new, more effective and better tolerated options with a higher genetic barrier to resistance are now available for adults, optimized treatment options for children lag significantly behind. This sixth edition of the Optimal Formulary and Limited-use List supports the transition to optimal WHO-recommended ART regimens for infants and children, while giving due consideration to the rapidly evolving treatment landscape and the risks inherent in the uncertain timelines for pediatric drug development.

This guide was created to support civil society to engage and contribute more effectively during the 2021 High-Level Meeting on HIV and AIDS (HLM). Unlike other HLM processes the majority, if not all, of the HLM activities, will be virtual. This means that it is especially important for advocates to find solutions to build their capacity, strengthen their networks and engage in advocacy virtually. This guide includes some important engagement opportunities and places to start on this journey.

The HLM Youth Guide has been developed by The PACT and UNAIDS to provide young people with information and guidance on what is and how to engage in the High-Level Meeting on HIV & AIDS that will take place from 8-10 June at the United Nations General Assembly. The intended audience of this Guide are young activists and youth-led organizations working on HIV and SRHR at all levels of the response, especially those key populations most affected by HIV.

The aim of this document is to assist national tuberculosis (TB) programmes in developing the strongest possible mechanisms of surveillance for drug resistance in TB, building on more than 25 years of global experience. This starts from periodic surveys of sampled patients, moving towards an ultimate goal of continuous surveillance systems based on routine drug susceptibility testing (DST). This guidance promotes certain standardized criteria for surveillance to ensure that results are comparable within and between countries over time. The target audience of this document is national TB programmes and, in particular, the coordination team for surveillance ideally composed of the programme manager, a laboratory specialist, a logistician, and an epidemiologist/statistician.

Through more than 10 years, UNDP has been supporting transitional justice processes with an integrated approach to support sustaining peace. This strategic report covers a wide range of UNDP’s support to transitional justice processes providing good practices, country cases and key strategic alliances with UN partners, such as OHCHR, UN Women, and UN peace missions. The key areas highlighted in the report are participatory processes, institutional transformation for proper accountability, reparations programmes and conflict prevention and sustaining peace to promote resilience and social cohesion for affected communities.

The 2009 Human Development Report Overcoming Barriers: Human Mobility and Development, made the case that human mobility not only contributes to improving the lives of migrants and their families, but is a driver of development in countries of origin and destination. It also proposed a package of reforms to enhance the development gains of human mobility. Human Mobility, Shared Opportunities: A Review of the 2009 Human Development Report and the Way Ahead looks at new patterns of human mobility, reviews progress made on recommendations in the previous report, analyses emerging challenges and sets out next steps.

A new report by the Global Fund to Fight AIDS, Tuberculosis and Malaria shows COVID-19 has massively disrupted health systems and health service delivery for HIV, TB and malaria in low- and middle-income countries in Africa and Asia in 2020. The report highlights the urgent need to scale up the adaptive measures that health facilities adopted to continue the fight against HIV, TB, malaria, to ramp up delivery of critical supplies for the COVID-19 response, and prevent health care systems and community responses from collapse.

My Body is My Own - Claiming the right to autonomy and self-determination. We have the inherent right to choose what we do with our body, to ensure its protection and care, to pursue its expression. The quality of our lives depends on it. In fact, our lives themselves depend on it.